Team
Information Box Group
Sonia Brookes
Administrative Assistant
Sonia Brookes
Administrative Assistant
Anastasia Chouvalov
RN, MSc
Patient Care and Research Coordinator
Anastasia Chouvalov
RN, MSc
Patient Care and Research Coordinator
Gerard Cox
Professor Emeritus
Department of Medicine
- Sarcoidosis
- Pulmonary fibrosis
- Bronchial thermoplasty
Anna D'Angela
BHSc-PA, CCPA, MBA, CHE
Physician Assistant
Anna D'Angela
BHSc-PA, CCPA, MBA, CHE
Physician Assistant
Jenielle Findlater
Administrative Assistant
Jenielle Findlater
Administrative Assistant
Andrea Gardner
RN BSN
Clinical Nurse Coordinator
Research Coordinator
Andrea Gardner
RN BSN
Clinical Nurse Coordinator
Research Coordinator
Layla Halwagi
HBSc
Research Coordinator
Layla Halwagi
HBSc
Research Coordinator
Nathan Hambly
Associate Professor
Department of Medicine
- Pulmonary hypertension
- Interstitial lung disease
- Sarcoidosis and acute exacerbations of idiopathic pulmonary fibrosis
Martin Kolb
Professor
Director, Division of Respirology
Department of Medicine
- Interstitial lung disease
- Mechanisms of lung injury, repair and fibrosis
Martin Kolb
Professor
Director, Division of Respirology
Department of Medicine
Barak Pertzov
MD, MPH
Clinical Research Fellow
Barak Pertzov
MD, MPH
Clinical Research Fellow
Ciaran Scallan
Assistant Professor
Department of Medicine
- Lung transplant
- Interstitial lung disease
- Connective tissue disease
Saryah Wahoush
Administrative Assistant
Saryah Wahoush
Administrative Assistant
Lindsey Walker
Administrative Assistant
Lindsey Walker
Administrative Assistant
Sonia Brookes
Administrative Assistant
Sonia Brookes
Administrative Assistant
Anastasia Chouvalov
RN, MSc
Patient Care and Research Coordinator
Anastasia Chouvalov
RN, MSc
Patient Care and Research Coordinator
Gerard Cox
Professor Emeritus
Department of Medicine
- Sarcoidosis
- Pulmonary fibrosis
- Bronchial thermoplasty
Gerard Cox
Professor Emeritus
Department of Medicine
- Sarcoidosis
- Pulmonary fibrosis
- Bronchial thermoplasty
Anna D'Angela
BHSc-PA, CCPA, MBA, CHE
Physician Assistant
Anna D'Angela
BHSc-PA, CCPA, MBA, CHE
Physician Assistant
Jenielle Findlater
Administrative Assistant
Jenielle Findlater
Administrative Assistant
Andrea Gardner
RN BSN
Clinical Nurse Coordinator
Research Coordinator
Andrea Gardner
RN BSN
Clinical Nurse Coordinator
Research Coordinator
Layla Halwagi
HBSc
Research Coordinator
Layla Halwagi
HBSc
Research Coordinator
Nathan Hambly
Associate Professor
Department of Medicine
- Pulmonary hypertension
- Interstitial lung disease
- Sarcoidosis and acute exacerbations of idiopathic pulmonary fibrosis
Nathan Hambly
Associate Professor
Department of Medicine
- Pulmonary hypertension
- Interstitial lung disease
- Sarcoidosis and acute exacerbations of idiopathic pulmonary fibrosis
Martin Kolb
Professor
Director, Division of Respirology
Department of Medicine
- Interstitial lung disease
- Mechanisms of lung injury, repair and fibrosis
Martin Kolb
Professor
Director, Division of Respirology
Department of Medicine
- Interstitial lung disease
- Mechanisms of lung injury, repair and fibrosis
Barak Pertzov
MD, MPH
Clinical Research Fellow
Barak Pertzov
MD, MPH
Clinical Research Fellow
Ciaran Scallan
Assistant Professor
Department of Medicine
- Lung transplant
- Interstitial lung disease
- Connective tissue disease
Ciaran Scallan
Assistant Professor
Department of Medicine
- Lung transplant
- Interstitial lung disease
- Connective tissue disease
Saryah Wahoush
Administrative Assistant
Saryah Wahoush
Administrative Assistant
Lindsey Walker
Administrative Assistant
Lindsey Walker
Administrative Assistant
ILD Program
At the McMaster ILD Clinic, we are dedicated to providing expert care for people with all forms of ILD. Managing these complex conditions requires a team approach. Our clinic brings together doctors, researchers, and patient advocates who collaborate to improve care and support for patients.
We offer thorough assessments, state-of-the-art diagnostic tools, and personalized treatment plans. Our team reviews each case carefully to ensure the best possible management of the disease and its symptoms. The ILD Program at McMaster is also committed to advancing research, education, and leadership in the field of lung disease to improve care for all patients.
SPECIALTY CLINICS
Respiratory-Rheumatology Clinic:
Dedicated multidisciplinary clinic providing subspecialty care to patients with pulmonary complications of connective tissue disease.
Renal-Respiratory-Rheumatology Clinic:
Dedicated multidisciplinary clinic providing subspecialty care to patients with pulmonary complications of vasculitis.
Sarcoidosis Clinic:
Dedicated multidisciplinary clinic providing subspecialty care to patients with sarcoidosis with multisystem involvement.
Information Box Group
ILD Research
- ALOFT-IPF (IM027-068)
- Title: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
- Disease group: IPF
- Principal Investigator: Martin Kolb
- Sponsor: Bristol Myers Squibb
- Link: A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis – Full Text View – ClinicalTrials.gov
- Status: Active, recruiting
- ALOFT-PPF (IM027-1015)
- Title: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
- Disease group: PPF
- Principal Investigator: Martin Kolb
- Sponsor: Bristol Myers Squibb
- Link: A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis – Full Text View – ClinicalTrials.gov
- Status: Active, recruiting
- AVALYN (AP01-007)
- Title: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study Evaluating the Safety and Efficacy of Pirfenidone Solution for Inhalation (AP01) in Subjects with Progressive Pulmonary Fibrosis (PPF)
- Disease group: PPF
- Principal Investigator: Martin Kolb
- Sponsor: Avalyn Pharma Inc.
- Link: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study Evaluating the Safety and Efficacy of Pirfenidone Solution for Inhalation (AP01) in Subjects with Progressive Pulmonary Fibrosis (PPF)
- Status: Active, recruiting
- BEACON-IPF (PLN-74809-IPF-206)
- Title: A Randomized, Double-blind, Dose-ranging, Placebo-controlled Study to Evaluate the Efficacy and Safety of Bexotegrast (PLN-74809) for the Treatment of Idiopathic Pulmonary Fibrosis
- Disease group: IPF
- Principal Investigator: Martin Kolb
- Sponsor: Pliant Therapeutics Inc.
- Link: Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis – Full Text View – ClinicalTrials.gov
- Status: Not yet active
- FIBRONEER-IPF (BI-1305-0014)
- Title: A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 Over at Least 52 Weeks in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Disease group: IPF
- Principal Investigator: Gerard Cox
- Sponsor: Boehringer Ingelheim
- Link: A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) – Full Text View – ClinicalTrials.gov
- Status: Active, not recruiting
- FIBRONEER-PFILD (BI-1305-0023)
- Title: A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 Over at Least 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
- Disease group: IPF
- Principal Investigator: Gerard Cox
- Sponsor: Boehringer Ingelheim
- Link: A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) – Full Text View – ClinicalTrials.gov
- Status: Active, not recruiting
- IMPALA-2 (SAV006-05)
- Title: A randomized, double-blind, placebo-controlled clinical trial of once-daily inhaled molgramostim nebulizer solution in adult subjects with autoimmune pulmonary alveolar proteinosis (aPAP)
- Disease group: aPAP
- Principal Investigator: Nathan Hambly
- Sponsor: Savara ApS
- Link: Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) – Full Text View – ClinicalTrials.gov
- Status: Active, not recruiting
- TETON-IPF (RINPF-301)
- Title: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
- Disease group: IPF
- Principal Investigator: Nathan Hambly
- Sponsor: United Therapeutics
- Link: Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis – Full Text View – ClinicalTrials.gov
- Status: Active, recruiting
- TETON-PPF (RINPF-305)
- Title: A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis
- Disease group: PPF
- Principal Investigator: Nathan Hambly
- Sponsor: United Therapeutics
- Link: Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) – Full Text View – ClinicalTrials.gov
- Status: Active, recruiting
- TRANSFORM
- Title: A Phase 2, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study (TRANSFORM) to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- Disease group: IPF
- Principal Investigator: Martin Kolb
- Sponsor: GSK
- Link: A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF) – Full Text View – ClinicalTrials.gov
- Status: Active, recruiting
- Observational Studies/Registries:
- Canadian Registry for Pulmonary Fibrosis (CARE-PF)
- CONNECT ILD
If you are interested in Research, please reach out to Victoria Bryczka at bryczkav@mcmaster.ca
Interstitial Lung Disease Fellowship
Since 2013, Canadian and international trainees have embraced the opportunity to pursue sub-specialty training in the ILD Fellowship Program at the Firestone Institute for Respiratory Health, McMaster University. Graduates of the program have gone on to develop and lead recognized ILD centres dedicated to clinical care, research, and education. The program’s objectives and curriculum are designed to foster a collaborative multi-disciplinary approach to the management of advanced parenchymal lung disease. Given our evolving understanding of the pathogenies of the various forms of ILD, the divergence and convergence of disease phenotypes, and the development of novel and complex therapeutic strategies to manage these conditions, there is a high demand to train physicians in order to catapult patient care.
Learn more
Fellowship Program Guide: (Available once accepted to Fellowship Program, email dvermunt@stjosham.on.ca for access)
ILD Patient Education
Navigation Groups
-
Medication Information
Learn more about the medications you may be prescribed
-
Testing Information
You may be scheduled for a specific procedure during your visit
-
Patient Resources
Materials you may find beneficial, including Podcasts, videos, ect.